Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.